Pulmonary Hypertension Associated with Connective Tissue Disease
- PMID: 34809915
- DOI: 10.1016/j.ccl.2021.08.003
Pulmonary Hypertension Associated with Connective Tissue Disease
Abstract
Pulmonary hypertension (PH), a syndrome characterized by elevated pulmonary pressures, commonly complicates connective tissue disease (CTD) and is associated with increased morbidity and mortality. The incidence of PH varies widely between CTDs; patients with systemic sclerosis are most likely to develop PH. Several different types of PH can present in CTD, including PH related to left heart disease and respiratory disease. Importantly, CTD patients are at risk for developing pulmonary arterial hypertension, a rare form of PH that is associated with high morbidity and mortality. Future therapies targeting pulmonary vascular remodeling may improve outcomes for patients with this devastating disease.
Keywords: Connective tissue disease; Diagnosis; Epidemiology; Outcomes; Pulmonary hypertension.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure Consultancies: Actelion, Acceleron, Bayer, United Therapeutics. Funding to institution: Actelion, United Therapeutics. NHLBI: U01HL125175 (Co-PI); R01HL134905 (Co-I); R01HL11490 (Co-I). DOD: PR191839 (PI). The clinical trial (NCT04797286) referenced in the article is supported by DOD grant PR191839 (PI-Mathai).
Similar articles
-
Pulmonary Hypertension Associated with Connective Tissue Disease.Rheum Dis Clin North Am. 2024 Aug;50(3):359-379. doi: 10.1016/j.rdc.2024.03.005. Rheum Dis Clin North Am. 2024. PMID: 38942575 Review.
-
Pulmonary hypertension in connective tissue diseases: epidemiology, pathogenesis, and treatment.Clin Rheumatol. 2023 Oct;42(10):2601-2610. doi: 10.1007/s10067-022-06446-y. Epub 2022 Nov 17. Clin Rheumatol. 2023. PMID: 36396789 Review.
-
Pulmonary hypertension in connective tissue diseases: What every CTD specialist should know - but is afraid to ask!Rev Med Interne. 2024 Jan;45(1):26-40. doi: 10.1016/j.revmed.2023.10.450. Epub 2023 Nov 2. Rev Med Interne. 2024. PMID: 37925256 Review.
-
Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): Recent and advanced data.Autoimmun Rev. 2024 Apr;23(4):103506. doi: 10.1016/j.autrev.2023.103506. Epub 2023 Dec 21. Autoimmun Rev. 2024. PMID: 38135175 Review.
-
Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis.Heart Fail Clin. 2023 Jan;19(1):45-54. doi: 10.1016/j.hfc.2022.08.016. Heart Fail Clin. 2023. PMID: 36435572 Review.
Cited by
-
Identifying the genetic association between rheumatoid arthritis and the risk of pulmonary arterial hypertension.Clin Rheumatol. 2025 Jan;44(1):153-160. doi: 10.1007/s10067-024-07258-y. Epub 2024 Dec 6. Clin Rheumatol. 2025. PMID: 39638962
-
Myocardial Disease in Systemic Sclerosis: Recent Updates and Clinical Implications.Curr Cardiol Rep. 2025 Jan 4;27(1):3. doi: 10.1007/s11886-024-02164-w. Curr Cardiol Rep. 2025. PMID: 39754676 Free PMC article. Review.
-
Effect size of rituximab on pulmonary function in the treatment of connective-tissue disease-related interstitial lung disease: a systematic review and meta-analysis.Respir Res. 2022 Jun 21;23(1):164. doi: 10.1186/s12931-022-02082-x. Respir Res. 2022. PMID: 35729565 Free PMC article.
-
2023 Taiwan Society of Cardiology (TSOC) and Taiwan College of Rheumatology (TCR) Joint Consensus on Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.Acta Cardiol Sin. 2023 Mar;39(2):213-241. doi: 10.6515/ACS.202303_39(2).20230117A. Acta Cardiol Sin. 2023. PMID: 36911549 Free PMC article.
-
Clinical Characteristics, Imaging Patterns and Management in Male and Female Patients with Primary Sjögren's Syndrome-associated Interstitial Lung Disease.Clin Rheumatol. 2025 Aug 8. doi: 10.1007/s10067-025-07578-7. Online ahead of print. Clin Rheumatol. 2025. PMID: 40781169
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical